Loading company…
New Biocalysis Technology in Wuhan makes raw materials for the bio-pharmaceutical and in-vitro diagnostics (IVD) industry.
New Biocalysis Technology develops, produces and supplies raw materials for bio-pharmaceutical and IVD reagent manufacturing. The company has developed more than 100 IVD reagent raw materials, used in vaccine production, molecular diagnosis and bio-sensing, and works with over 100 IVD reagent manufacturers. Established in 2015 in Wuhan, China, it sells to customers in 25 countries and is at the Series C stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in